/home/wpurdemo/resistancesuffolk/wp-content/mu-plugins
Her Accomplishments
(Letter to the Editor from this week in the East Hampton Star)
Bridget Fleming has served as a Suffolk County legislator for the past two years, and in that time has distinguished herself as someone who gets results.
Her accomplishments include helping to secure more than $2.5 million in clean water and infrastructure funding for our district, as well as getting funding for a program to reduce the tick population and address the public health crisis of tick-borne diseases. Bridget has also been an outspoken critic against cuts to public bus service, traveling to Albany to advocate for Suffolk County receiving its fair share of the New York State budget.
Voting for Bridget Fleming on Nov. 7 will ensure that the East End continues to benefit from her outstanding work on many issues.
Sincerely, CAROL DEISTLER
]]>Dear Editor,
To anyone living on the East End it is apparent that tick-borne diseases are a health crisis. We need the federal government to provide funding on both the local and national level for this public health emergency. And yet the Trump administration’s proposed budget cuts funding to the National Institutes of Health by 20 percent (nearly $6 billion) and to the Centers for Disease Control and Prevention by 17 percent ($1.2 billion).
Lee Zeldin, we need you to stand up to your own party and demand that funding be increased to these entities. If we’ve seen anything over the past decades, it’s that diseases can be controlled, and in some cases eradicated, by the dedicated efforts of legislators who care enough to fight for funding so that researchers and physicians have the resources to tackle these problems.
CAROL DEISTLER, Springs
I checked the NIH funding for Lyme disease for CD-1 versus the entire state of NY (in dollars x 1000), see below. * projected numbers are provided by the NIH but are subject to budget changes dictated by Congress.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |
| NYS | 1880 | 1766 | 2539 | 2207 | stable* | decrease* |
| CD1 | 657 | 691 | 767 | 236 | ||
| % CD1/NYS | 0.34 | 0.39 | 0.30 | 0.10 |
Note the slippage in the share of NIH research dollars for CD-1 since Zeldin has been in office (2014). We have gone from 39% to 10% of state wide funding for Lyme Disease Research in CD-1. That is nothing to brag about.
Source: https://report.nih.gov/categorical_spending.aspx
David Posnett MD
]]>